trending Market Intelligence /marketintelligence/en/news-insights/trending/HuaaskiDHwhME7JdhsXG7A2 content esgSubNav
In This List

Veritas Pharma CFO resigns; interim replacement named

Blog

Essential IR Insights Newsletter Fall - 2023

Case Study

A Corporation Clearly Pinpoints Activist Investor Activity

Blog

Insight Weekly: Bank mergers of equals return; energy tops S&P 500; green bond sales to rise

Blog

Insight Weekly: US companies boost liquidity; auto insurers hike rates; office sector risk rises


Veritas Pharma CFO resigns; interim replacement named

David Alexander resigned as the CFO and a director of Veritas Pharma Inc.

The company appointed Peter McFadden to replace Alexander as CFO on an interim basis.

Veritas Pharma develops proprietary cannabis strains for chronic and acute pains, nausea and vomiting, and post-traumatic stress disorders.